Incidence of Stroke in Isparta Province Turkey

G. AKHAN, S. KUTLUHAN, N. EREN, H. R. KOYUNCUOĞLU, S. DEMİRCİ

Issue: 1999, Volume 5 - Issue 2
0 245

The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 228

Migraine and Association of Migraine and Epilepsy: A prevalence study

Y. ÖZKUL, A. AKYÜZ, K. TOPALKARA, Ş. DENER, S. TOPAKTAŞ

Issue: 1999, Volume 5 - Issue 1
0 239

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 219

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 306

Ege Stroke Data Bank: An Analysis of 2000 Patients With Stroke

Emre KUMRAL, Bekir ÖZKAYA, Egemen VARDARLI, Ayşe SAĞDUYU, Hadiye ŞİRİN, Murat PEHLİVAN

Issue: 1997, Volume 3 - Issue 1-2
0 228

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 268

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 379

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 222

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 224

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 326

Creutzfeldt-Jakob Disease: Report of Two Cases and Review of Turkish Literature

Aytaç YİĞİT, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1995, Volume 1 - Issue 2
0 190

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 401

The lmmunopathogenesis of Multiple Sclerosis

Nihal Işık

Issue: 2009, Volume 15 - Supplement 3
0 346

Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis

Rana KARABUDAK

Issue: 2009, Volume 15 - Supplement 3
0 384

Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies

Muhteşem GEDİZOĞLU

Issue: 2009, Volume 15 - Supplement 3
0 291

Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports

Murat TERZİ

Issue: 2009, Volume 15 - Supplement 3
0 428

The influence of self-care agency on quality of life in patients with multiple sclerosis

Ahsen Taştan Gürkan, Afitap Özdelikara

DOI: 10.55697/tnd.2024.9

Issue: 2024, Volume 30 - Issue 3
746 415

Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning

İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi

DOI: 10.55697/tnd.2024.107

Issue: 2024, Volume 30 - Issue 3
712 357

The relationship between lesion volume, oligoclonal bands, and cerebrospinal fluid/serum albumin ratio in multiple sclerosis

Güllü Tarhan, Burçe Akbağra Kaya, Arif Musab Akıner, Yaren Betül Yılmaz, Saime Füsun Domaç

DOI: 10.55697/tnd.2024.88

Issue: 2024, Volume 30 - Issue 4
406 339